Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin specific peptidase 17-like family member 17 (USP17L17) is a protein-coding gene that encodes a **deubiquitinating enzyme** involved in the removal of conjugated ubiquitin from target proteins, thereby regulating various cellular processes such as **cell proliferation, apoptosis, cell migration, cell cycle progression**, and the **cellular response to viral infection**[1][2][7][13]. It is predicted to be located in the **endoplasmic reticulum, cytosol, and nucleus**, has cysteine-type endopeptidase and deubiquitinase activity, and plays a role in regulating protein stability[2][3][4][6][12]. While USP17 family members are broadly implicated in cancer and cell homeostasis, there are currently **no known drugs** specifically targeting USP17L17, nor established biomarkers or significant safety data[2][13].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 17-like family member 17 (USP17L17).